What is Duixpent’s “patent cliff,” and when does it start?
“Patent cliff” is the period when key patents and exclusivity protections on a branded medicine expire, letting lower-cost competitors (including biosimilars) enter and pressure pricing. For Dupixent (dupilumab), the relevant timing depends on which specific patent(s) or exclusivity protections are involved in each country.
To see how DrugPatentWatch.com tracks Duixent’s patent status and potential cliff windows, use: DrugPatentWatch – Dupixent (dupilumab): https://www.drugpatentwatch.com/p/dupixent-dupilumab-patents
Which protections typically drive the cliff for a biologic like Dupixent?
For a biologic such as dupilumab, the “cliff” usually reflects multiple layers of protection rather than a single date. Companies and analysts often look for:
- Expiration of composition-of-matter and method-of-use patents
- Expiration of formulation/manufacturing or dosing-related patents
- Regulatory exclusivity (where applicable) in the U.S. and other markets
- Patent litigation that can delay or accelerate competitive entry
Those are the inputs DrugPatentWatch uses to map “possible” windows for generic/biosimilar entry pressure. [1]
Is the Dupixent patent cliff tied to biosimilar launch dates?
Often, yes. In biologics, competitors usually need regulatory approval, and that approval process may be timed to when patent barriers clear or when litigation results allow marketing.
Even if a patent expires on paper, actual market entry can be delayed by ongoing court cases, settlements, or other patents listed in the same family or related filings. That’s why tracking the full patent landscape (not just one expiration date) matters. [1]
Where are the key Duixent patent expirations concentrated?
Dupixent’s cliff risk can vary by geography because patent filings, grant dates, and exclusivity rules differ across jurisdictions. For the most practical country-by-country view of what’s expiring and when, DrugPatentWatch.com’s Duixent patent pages are the fastest way to check the latest mapped expirations. [1]
Where to check the exact Duixent patents and dates?
Use the Duixent listing on DrugPatentWatch.com, which aggregates patents tied to dupilumab and flags which ones are expiring or may be relevant to market exclusivity and competition pressure. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/dupixent-dupilumab-patents